The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Swedish Study Indicates LDL Cholesterol Not a Good Marker of Cardiovascular Risk in Type 1 Diabetes
June 18th 2014Researchers find that the ratio of total cholesterol to HDL is a significant predictor for CVD in type 1 diabetes patients who are not using lipid-lowering drugs, and that the ratio of total cholesterol to HDL is a more reliable marker for risk when considering primary prevention.
Durability Seen in Clinical Cardiology Guideline Recommendations Based on Multiple Randomized Trials
Cardiology guideline recommendations that are based on multiple randomized studies have the most durability over time, researchers from the University of Pennsylvania have found.
Novel Orally Available GLP-1 Agonist Lowers HbA1c in Patients with Type 2 Diabetes
June 16th 2014Study results show that an alternative to currently-marketed injectable agents retains the efficacy of GLP-1 mimetics, while reducing gastrointestinal adverse events and providing the convenience of oral dosing.
Snoring in Pregnant Hypertensive Women a Marker for Apnea Risk
Pregnant women with hypertension who also snored were found to be at high risk for obstructive sleep apnea, spurring the need for obstetric healthcare providers to consider sleep evaluation in hypertensive pregnancies.
What's the Story with Testosterone Replacement Therapy and Diabetes?
Just weeks after Australian researchers published data suggesting that testosterone replacement therapy does not ameliorate type 2 diabetes among hypogonadal men, a team of American researchers has unveiled a second study that suggests just the opposite.
Aggressive Management of Obesity and Other Atrial Fibrillation Risk Factors
A new study indicates that treating hyperlipidemia, glucose intolerance, high blood pressure, sleep apnea, and other risk factors associated with atrial fibrillation can dramatically reduce the burden of the disease or eliminate it entirely.
American Society of Hypertension 2014 Annual Scientific Meeting
June 2nd 2014The American Society of Hypertension (ASH) is the largest US professional organization dedicated to eradicating hypertension and its consequences. The following study presentations were highlights of the organization's 29th annual meeting in New York City.